ArticlebioRxiv : the preprint server for biology2025
The protein interactome of the Neuron Specific Gene family (NSG1-3).
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The Neuron-Specific Gene (NSG) family members (NSG1-3) play critical and diverse roles in neuronal protein trafficking, but their precise molecular functions remain poorly understood. Here, we employed proximity-labeling proteomics to map the interactomes of each NSG protein. Unlabeled mass spectrometry identified over 1,000 significantly enriched interactors compared with a cytoplasmic control, revealing substantial overlap between NSG1 and NSG2, and a more divergent profile for NSG3. Gene ontology and KEGG pathway analysis confirmed established associations with glutamatergic synapses and endosomal trafficking, while also uncovering unexpected links to presynaptic machinery, inhibitory synapses, and endoplasmic reticulum-associated protein translation, particularly for NSG3. Reciprocal biotinylation patterns and co-immunoprecipitation revealed novel heteromeric complex formation between NSG1 and NSG2, with limited interactions involving NSG3. All three NSGs biotinylated core AMPA receptor subunits and auxiliary proteins, while NSG1 and NSG2 also associated with NMDA receptors, GABA receptor subunits, as well as multiple presynaptic proteins. Moreover, NSG1 and NSG2 specifically biotinylated components of multiunit tethering complexes including neuron-specific retromer, and biotinylated a preponderance of ADAM10 substrates, reinforcing their role in proteolytic processing. Finally, despite the relatively divergent interactomes of NSG1 and NSG2 compared to NSG3, all family members robustly biotinylated amyloid precursor protein (APP), suggesting possible synergistic or competitive interactions that could shape APP proteolytic processing and/or trafficking. Together, these data provide a comprehensive systems-level view of NSG protein interactions, establishing a molecular framework for future investigations into NSG-mediated neural plasticity and disease mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.